Keyword: Contract Development And Manufacturing Organizations (CDMO)


Catalent Opens Cell Therapy Facility in Belgium

13.12.2022 -

Catalent has opened a new commercial-scale cell therapy manufacturing facility at its European center of excellence for cell therapies in Gosselies, Belgium.


Flow Chemistry

07.12.2022 -

Executives and industry experts share their views on drivers as well as barriers for the use of flow chemistry in pharmaceutical manufacturing and the prospect for this...


Catalent Completes Shanghai Plant Expansion

06.12.2022 -

US-headquartered CDMO giant Catalent has completed the expansion of its clinical supply facility in the Waigaoqiao Free Trade Zone (FTZ) in Shanghai, China.


Change of Ownership for US CDMO Alcami

10.11.2022 -

UK specialist healthcare investor GHO Capital Partners and US investment firm The Vistria Group have entered into an agreement to buy a controlling interest in US CDMO...


Curia Begins Work on New Mexico Expansion

02.11.2022 -

US CDMO Curia has begun construction on an expansion of its campus in Albuquerque, New Mexico. The facility designed by Burns & McDonnell will be built by BE&K Building...


Recipharm Bolsters Blow-Fill-Seal Capabilities in France

31.10.2022 -

Swedish multinational CDMO Recipharm has bolstered its sterile filling capabilities at its facility in Kaysersberg, France, by installing Lab+ continuous automated...


Symeres Strengthens US Foothold with Exemplify Buy

27.10.2022 -

Dutch CDMO Symeres has acquired Exemplify Biopharma, a US-based contract research organization (CRO) based in Cranbury, New Jersey, USA. The deal further strengthens...


Catalent to Invest $12 Million at Kansas City

26.10.2022 -

Catalent has announced a $12 million expansion program to increase biologics CGMP analytical capabilities at its flagship facility in Kansas City, Missouri.